The Market Influence of The Impact Of Infectious Diseases On Global Health And The Healthcare Industry: How It’s Propelling Blood Culture Tests Market Growth and Size in 2025

The Business Research Company’s report on the Blood Culture Tests Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

How are market drivers shaping the future growth trajectory of the blood culture tests industry?

The increase in incidence of infectious diseases is expected to propel the growth of the blood culture test market. Infectious diseases are illnesses caused by pathogens, including viruses, bacteria, fungi, and parasites. These diseases have dangerous microorganisms or pathogens that enter an individual’s body from the outside or from an infected person. These infectious diseases, such as COVID-19, tuberculosis, flu, measles, HIV, strep throat, and so on, have the potential to cause momentary pain, significant tissue damage, or even death. The World Health Organization ranks infectious diseases as the second biggest cause of death globally. These increases in the incidence of infectious diseases have led to an increase in the demand for blood culture tests to assist in determining whether a patient has bacteremia/septicemia, a potentially fatal condition, or not. For instance, in August 2024, according to a report published by the Uk Health Security Agency, a UK-based government agency, as of December 31, 2022, there were 3,732 confirmed mpox cases in the UK, with most in England. By May 31, 2023, there were 21 more cases reported, mainly in England and one in Scotland. Therefore, the increasing incidence of infectious diseases is driving the growth of the blood culture test market.

Access Your Free Sample of the Global Blood Culture Tests Market Report – Get Insights Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7763&type=smp

What is the estimated market size of the blood culture tests sector by 2029, based on current forecasts?

The blood culture tests market size has grown rapidly in recent years. It will grow from $6.79 billion in 2024 to $7.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increase in prevalence of infectious diseases, aging population, advances in healthcare infrastructure, rise in research and development.

The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to $13.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to rising hospital-acquired infections, growing demand for point-of-care (poc) testing, increased healthcare spending, regulatory approvals. Major trends in the forecast period include telemedicine and remote testing, automation and ai, multiplex testing, sepsis management, infectious disease surveillance.

Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7763&type=smp

Who are the top players in the blood culture tests market?

Major companies operating in the blood culture tests market include Becton, Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, Terumo Corporation, Bruker Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Bulldog Bio, Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Axiom Laboratories, Biosystems Inc., BINDER GmBH, Roche Diagnostics, Mikroscan Technologies Inc., Labotronics Ltd., Hardy Diagnostics, OpGen Inc., Meditech Technologies India Private Limited, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Hologic Inc., Quidel Corporation, Copan Diagnostics Inc., Greiner Bio-One International GmbH, Carl Zeiss AG, Nanosphere Health Sciences, GenMark Diagnostics, Meridian Bioscience Inc., Nikon Corporation

What are the major trends in the blood culture tests market?

The technological innovation is a key trend gaining popularity in the blood culture tests market. Innovation and globalization are creating new prospects for the pharmaceutical, biologics, nutraceuticals, and medical device industries. The desire to bring new products to market safely, quickly, and affordably necessitates producers and manufacturers to build world-class blood culture testing to demonstrate compliance with ever-expanding requirements. These technological innovations reduce costs through accurate and independent safety and performance assurance. For instance, In May 2022, Labcorp, a US-based testing laboratories company, launched Labcorp OnDemandTM at-home collection kit that measures hemoglobin A1c (HbA1c) from a small blood sample. This OnDemand Diabetes test kit employs dried blood technology to provide an overview of the body’s average blood sugar levels over time. Through this kit, users can monitor their health status regularly from the comfort of their homes with a prick of the finger and a few drops of blood.

Which geography holds the highest blood culture tests market share?

North America was the largest region in the blood culture tests market in 2024. The regions covered in the blood culture tests market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Order Your Report Now For Swift Delivery

https://www.thebusinessresearchcompany.com/report/blood-culture-tests-global-market-report

How do different segments contribute to the overall expansion of the blood culture tests market?

The blood culture tests market covered in this report is segmented –

1) By Method: Conventional/Manual Methods, Automated Methods

2) By Product: Consumables, Instruments, Software and Services

3) By Technology: Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-FiSH (Peptide Nucleic Acid – Fluorescent in Situ Hybridization), Proteomics Technology

4) By Application: Bacteremia, Fungemia, Mycobacterial Detection

5) By End User: Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories

Subsegments:

1) By Conventional/Manual Methods: Blood Culture Bottles (Aerobic and Anaerobic), Culture Media Preparation, Manual Observation and Identification

2) By Automated Methods: Automated Blood Culture Systems, Continuous Monitoring Systems, Integrated Identification and Sensitivity Testing Systems

Purchase The Exclusive Report Now To Unlock Valuable Market Insights:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7763

How is the blood culture tests market defined, and what are its core characteristics?

Blood culture tests refer to blood tests used to detect and identify disease-causing microorganisms in the bloodstream. A blood culture test checks for infections caused by microorganisms like bacteria, yeast, and other foreign invaders in a blood sample.

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company